Educational information, not medical advice — ask your doctor or midwife.
Agastache scrophulariifolia, or purple giant hyssop, is a tall mint-family plant from eastern North America. Despite the name, it is not a true hyssop. Gardeners and beekeepers grow it for its late-summer flowers.
The leaves smell faintly of anise and mint. People have dried them and brewed them as a tea. Today the plant is sold mostly as seed or as a garden plant, rarely as a packaged supplement.
Here is the honest verdict. There are no human trials on this plant for any health use. Traditional use shows that people valued it, but it is not proof that the plant works, and it is not proof that it is safe.
Most lab work on the genus has used its better-known cousins, such as Agastache rugosa and Agastache foeniculum. Findings from those plants do not transfer to this one. Different species in the same genus can differ a lot in their oils.
If you are deciding whether to try it, treat it as a pleasant aromatic tea plant with an unknown health profile, not as a treatment.
No one has shown how this plant acts in the human body, because that work has not been done.
What exists is lab work on related Agastache species. In test tubes, their essential oils slow the growth of some bacteria and fungi. Whether that happens in a person drinking a tea is not established.
In cell studies, extracts of Agastache rugosa appear to reduce some markers of inflammation. These are early findings in dishes, not in people. They say nothing about relief of any symptom.
The traditional idea was simpler. A warm, aromatic tea makes you sweat, soothes the throat and settles the stomach. Warm fluid and steam do some of that on their own, whatever herb is in the cup.
So the fair summary is that the mechanism is unknown, and the plausible benefits are modest and non-specific.
This plant is not a mainstream supplement, so your options are limited.
You are most likely to meet it as:
- dried leaf and flower, brewed as a herbal tea - fresh leaf from a garden, used as a flavouring - a rare tincture (an alcohol extract) from small herbal suppliers - honey from hives near the flowers, which is a food, not a remedy
An essential oil can be distilled from the plant, but it is uncommon and is not meant to be swallowed.
There is no standard extract, no agreed strength and no quality standard for this species. Products labelled "giant hyssop" may contain a different Agastache species. If you buy it, buy from a seller who names the full botanical name.
Purple giant hyssop appears in listings of medicinal plants of North America, and it had a modest place there.
Records of Native American plant use describe Agastache species being brewed as hot teas. Reported uses included colds, chest complaints and sweating out a fever. Records often name the genus loosely, so uses attributed to this exact species are uncertain.
Settler and later folk herbalists treated it much like other aromatic mints. It was a kitchen and dooryard plant more than a serious medicine.
It never entered the official medical texts of the nineteenth century in the way that plants such as goldenseal or boneset did. Modern herbalists mention it rarely.
This history is background, not a recommendation to use the plant yourself.
Stop using it and see a doctor if you develop a rash, swelling of the face or lips, wheeze or belly pain.
Go to an emergency department if you have trouble breathing or swallowing, or if your throat or tongue swells.
See a doctor rather than continuing the tea if a cough lasts more than three weeks, if you cough up blood, if a fever goes above 39C, or if a cold is still getting worse after ten days.
In the United States it may be sold as a herbal tea or dietary supplement. It is not an approved medicine there. In the UK, EU, Canada and Australia it is not a licensed herbal medicine, and no health claim may be made for it.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.